A trial of Triferic for treatment of iron-refractory iron-deficiency anemia

Trial Profile

A trial of Triferic for treatment of iron-refractory iron-deficiency anemia

Planning
Phase of Trial: Phase II

Latest Information Update: 24 Feb 2016

At a glance

  • Drugs Ferric pyrophosphate (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2016 New trial record
    • 22 Feb 2016 According to a Rockwell Medical Technologies media release, the company has filed an Investigative New Drug (IND) application.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top